|
|
||||||||
AJP - Endocrinology and Metabolism, Vol 265, Issue 2 E179-E183, Copyright © 1993 by American Physiological Society
ARTICLES |
E. N. Cozza and C. E. Gomez-Sanchez
Department of Internal Medicine, University of South Florida Health Sciences Center, Tampa.
Endothelin-1 (ET-1) exerts the following two types of aldosterone-stimulating actions on glomerulosa cells: ET-1-mediated direct stimulation of aldosterone secretion (per se effect) and potentiation of the aldosterone secretion to angiotensin II (ANG II; potentiation effect). The role of Ca2+ and protein kinase C (PKC) systems in these two effects was investigated. Incubations of calf cultured adrenal zona glomerulosa cells in low-Ca2+ media or in the presence of the Ca2+ channel antagonist verapamil reduced the aldosterone secretion to ET-1. When cells were preincubated with ET-1 in a low-Ca2+ media or in the presence of the Ca2+ channel antagonist verapamil, washed, and incubated in media with normal Ca2+, ANG II showed potentiation of ANG II-stimulated aldosterone secretion. The PKC inhibitors H-7 and staurosporine did not decrease ET-1-stimulated aldosterone secretion, but they inhibited the potentiation effect of ET-1 on ANG II-mediated aldosterone secretion. Adrenocorticotropic hormone desensitization or prolonged phorbol ester stimulation of PKC resulting in desensitization also resulted in the abolition of the ET-1-mediated ANG II potentiation of aldosterone secretion. The PKC inhibitors did not affect ANG II-stimulated aldosterone secretion. We conclude that ET-1 exerts a direct stimulation of aldosterone secretion through a mechanism dependent on Ca2+ and potentiates ANG II-mediated aldosterone stimulation through a mechanism involving PKC.
This article has been cited by other articles:
![]() |
T. Quaschning, F. Ruschitzka, B. Niggli, C. M. B. Lunt, S. Shaw, M. Christ, M. Wehling, and T. F. Luscher Influence of aldosterone vs endothelin receptor antagonism on renovascular function in liquorice-induced hypertension Nephrol. Dial. Transplant., November 1, 2001; 16(11): 2146 - 2151. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. G. Nussdorfer, G. P. Rossi, L. K. Malendowicz, and G. Mazzocchi Autocrine-Paracrine Endothelin System in the Physiology and Pathology of Steroid-Secreting Tissues Pharmacol. Rev., September 1, 1999; 51(3): 403 - 438. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Belloni, G. P. Rossi, P. G. Andreis, G. Neri, G. Albertin, A. C. Pessina, and G. G. Nussdorfer Endothelin Adrenocortical Secretagogue Effect Is Mediated by the B Receptor in Rats Hypertension, May 1, 1996; 27(5): 1153 - 1159. [Abstract] [Full Text] |
||||
![]() |
G. Rossi, A. S. Belloni, G. Albertin, L. Zanin, M. A. Biasolo, G. G. Nussdorfer, G. Palu, and A. C. Pessina Endothelin-1 and Its Receptors A and B in Human Aldosterone-Producing Adenomas Hypertension, April 1, 1995; 25(4): 842 - 847. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |